|
Verzögert
OTC Markets
18:36:54 16.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 0.0272 USD | -18.32% |
|
-9.33% | +4.62% |
| 19.05. | Adaptimmune Therapeutics plc meldet Ergebnisse für das am 31. Dezember 2025 abgeschlossene Geschäftsjahr | CI |
| 17.11. | Adaptimmune Therapeutics plc kündigt Wechsel in der Geschäftsführung an | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -18.32% | -9.33% | +8.80% | -31.49% | +4.62% | -86.07% | -95.91% | -99.48% | -99.48% | 8.83 Mio. | |
| +0.65% | +7.00% | +10.90% | +7.93% | +17.41% | +54.00% | +104.63% | +428.01% | +1’506.81% | 1’116 Mrd. | |
| +0.75% | -2.51% | -4.64% | +1.96% | +23.16% | +32.67% | +61.80% | +59.18% | +115.11% | 610 Mrd. | |
| +0.56% | +3.01% | +8.49% | +11.95% | +24.64% | +25.53% | +93.44% | +165.10% | +373.56% | 501 Mrd. | |
| +1.14% | +0.84% | +1.32% | +15.04% | +39.49% | +74.96% | +40.99% | +90.32% | +138.67% | 358 Mrd. | |
| -0.13% | +5.98% | +4.61% | +14.35% | +15.54% | +32.91% | +50.39% | +4.19% | +62.96% | 366 Mrd. | |
| -0.95% | +4.70% | +9.12% | +1.17% | +13.78% | +19.51% | +43.00% | +63.39% | +67.38% | 288 Mrd. | |
| -1.98% | +3.73% | +2.55% | -1.44% | -9.75% | -0.86% | +13.43% | +43.07% | +150.20% | 261 Mrd. | |
| +0.10% | +4.74% | +15.46% | +16.94% | +32.76% | +46.89% | +51.47% | +113.92% | +167.21% | 235 Mrd. | |
| -0.68% | +3.46% | +5.90% | +14.75% | +27.42% | +32.71% | +97.47% | +137.33% | +115.31% | 195 Mrd. | |
| -1.46% | +1.70% | -4.77% | -22.69% | -20.18% | -29.07% | -63.28% | -22.18% | +90.46% | 175 Mrd. | |
| +0.32% | +4.44% | +7.56% | +17.48% | +18.61% | +21.89% | -11.23% | -28.52% | -9.12% | 168 Mrd. | |
| -1.15% | -1.30% | -1.91% | +3.58% | +11.05% | +23.21% | +34.61% | +178.45% | +525.39% | 129 Mrd. | |
| -0.17% | +2.40% | -4.81% | +0.05% | +12.24% | +39.53% | +5.89% | +6.32% | +22.70% | 124 Mrd. | |
| +0.21% | +6.66% | +12.85% | +19.02% | +22.07% | +29.13% | +119.93% | +398.68% | +523.31% | 116 Mrd. | |
| -0.30% | +0.59% | -3.24% | -6.50% | -13.03% | -16.67% | -30.75% | -12.97% | +5.98% | 96.85 Mrd. | |
| -0.32% | +6.43% | -0.16% | -4.78% | +2.08% | +13.98% | +24.73% | +6.76% | -10.51% | 99.22 Mrd. | |
| -9.44% | -5.15% | +46.56% | +237.96% | +623.70% | +686.37% | +132.13% | -36.26% | - | 94.42 Mrd. | |
| -0.20% | +6.48% | +2.62% | +17.08% | +2.99% | +39.66% | -5.78% | +46.26% | +116.76% | 79.52 Mrd. | |
| +0.73% | +4.68% | +9.57% | +4.60% | +17.70% | +29.01% | -3.38% | -25.27% | +48.58% | 69.78 Mrd. | |
| Durchschnitt | -1.58% | +6.52% | +6.34% | +15.85% | +43.32% | +53.47% | +33.18% | +75.82% | +205.86% | 254.06 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.08% | +5.18% | +5.87% | +11.45% | +28.46% | +46.11% | +58.81% | +152.07% | +459.10% |
- Börse
- Aktien
- A14SUX Aktie
- Sektor Adaptimmune Therapeutics plc
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
